Monkeys in Labs: A Big Change in How We Do Science

The CDC, a major health agency, is making a significant change in how it conducts research. For years, the agency has used monkeys to test new medicines and treatments. However, that is about to change.

The Decision

The decision to end monkey testing came from Robert F. Kennedy Jr., who oversees health in the U.S. He directed the CDC to halt all monkey testing by the end of the year. This is a substantial shift, as many believed monkey testing would continue for a long time.

The Impact

Currently, the CDC has approximately 200 monkeys. These monkeys may be sent to sanctuaries or, unfortunately, euthanized. The agency claims they conducted a review and concluded that this change aligns with their mission.

Potential Consequences

This change could significantly impact Alpha Genesis, a company that breeds monkeys for research and operates a large facility in South Carolina. The CDC has purchased monkeys from them in the past. The implications for Alpha Genesis are unclear, but this change could be substantial for them.

Mixed Reactions

The decision has sparked mixed reactions. Justin Goodman, who works with the group White Coat Waste, has long advocated for this change. He sees it as a victory for animals and taxpayers. He has collaborated with politicians like Nancy Mace to support this cause.

However, not everyone is pleased. Some scientists may disagree with this change, believing that monkey testing is crucial for developing new treatments. This shift could have a significant impact on the future of scientific research.